InvestorsHub Logo

Bill B

01/29/21 10:18 AM

#34613 RE: mantis #34611

Not all of that revenue goes to relief. A large percentage would go to neurorx.

FitzyP33

01/29/21 11:09 AM

#34627 RE: mantis #34611

I can do math - thanks. As others have pointed out there is a mix/sharing revenue issue to account for but let's just say the mix shaves the revenue down to $2.5 billion. That's good, but that's a one time event and won't be sustained beyond at best 18 to 24 months. So at 4 X that's $10 billion of MC or 6 to 7 times from here or $3.00 to $3.50 stock price. I can see it spiking to there intraday, but not staying there once everyone looks realistically at valuation. BTW that's nowhere near $10/share. I saw someone say $30.00 and I thought that was nuts.

To be clear I am long 10K from $0.255 and hope I am wrong and others are right. I will be selling on any big early spike and not waiting for $30. I may regret selling, but I doubt it.